● Recruiting

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Condition: IGF1 Deficiency · Sponsor: Esteve Pharmaceuticals, S.A.

PhaseN/A

Planned participants500

Who can joinAll sexes, 2 Years to 18 Years

Healthy volunteersNo

About this study

The Increlex® Global Registry is a descriptive, multicenter, observational, prospective, open-ended, non interventional, post-authorisation surveillance registry. The main purpose of this global registry is to collect, analyse and report safety data during and up to at least 5 years after the end of treatment in children and adolescents receiving Increlex® therapy for SPIGFD according to the locally approved product information.

This description comes directly from the study's public registry record.

Talk to the study team

Esteve Global Clinical Development · increlexregistry@esteve.com

Always discuss trial participation with your own doctor first.

Locations (58)

Children's Hospital of Orange County	Orange, California, United States	Recruiting
University of Miami Leonard M Miller	Miami, Florida, United States	Recruiting
University Of Miami Leonard M. Miller	Miami, Florida, United States	Recruiting
D&H National Research Centers	Miami, Florida, United States	Withdrawn
Cincinnati Children's Hospital Medical Center	Cincinnati, Ohio, United States	Recruiting
UT Southwestern Medical Center	Dallas, Texas, United States	Not Yet Recruiting
Children's Health Specialty Center West Plano	Plano, Texas, United States	Withdrawn
Salzkammergut-Klinik Vöcklabruck	Vöcklabruck, Austria	Recruiting
Hôpital Amiens-Picardie	Amiens, France	Terminated
Centre Hospitalier de Blois	Blois, France	Recruiting
Hôpital Jean Verdier	Bondy, France	Recruiting
Hôpital Femme Mère-Enfant	Bron, France	Recruiting

+ 46 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00903110